(Q44110703)

29 November 2017

title

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial (English)

1 reference

primary biliary cholangitis

29 November 2017

main subject

0 references

author name string

George V Papatheodoridis

1

1 reference

29 November 2017

Emilia S Hadziyannis

2

1 reference

29 November 2017

Melanie Deutsch

3

1 reference

29 November 2017

Stephanos J Hadziyannis

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

The American Journal of Gastroenterology

29 November 2017

published in

1 reference

29 November 2017

volume

97

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

2063-2070

1 reference

Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

Primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05923.X

10.1111/J.1572-0241.2002.05923.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference